A randomized phase II study comparing consolidation with a single dose of Y-90 ibritumomab tiuxetan vs. maintenance with rituximab for two years in patients with newly diagnosed follicular lymphoma responding to R-CHOP. Long-term follow-up results LEUKEMIA LYMPHOMA
Pomalidomide, bortezomib, and dexamethasone at first relapse in lenalidomide-pretreated myeloma: A subanalysis of OPTIMISMM by clinical characteristics EUR J HAEMATOL
Clinico-biological features and outcome of patients with splenic marginal zone lymphoma with histological transformation BRIT J HAEMATOL